<< Read Full Article
<< Read Full Article
In this week's checkup on health care and biotech funds, TheStreet.com Ratings found the industry's performance to be pretty healthy.
Of the 97 health care and biotech funds we track, 87 rose in value, nine fell, and one was unchanged. The group averaged a total return of 0.86% for the four trading days from the close on Thursday, April 5, through Thursday, April 12.
On March 22, my article on HealthShares highlighted 14 new ETFs that cover highly specialized areas of the health care industry. With their individual lack of diversification, it is no surprise that four of these funds wasted no time in making our top- and bottom-performing lists this week. One became the best-performing with another setting the low mark. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,342.04 | 1,095.01 | 2,142.82 | 32.01 |
Oil *
78.40
|
|
UP
32.12
|
UP
3.52
|
UP
4.38
|
DOWN
0.30
|
10 Yr
3.20%
SPDR Gold
115.70
|
|
+0.31%
|
+0.32%
|
+0.20%
|
-0.93%
|
Data delayed 20 minutes |
Connect with TheStreet